Prasanth Surampudi, M.D.

Prasanth Surampudi, M.D.

Specialties

Internal Medicine

Endocrinology, Diabetes, and Metabolism

Title

  • Assistant Professor
To see if Prasanth Surampudi is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0400
Sacramento, CA 95817
Driving Directions

Primary Phone:
916-734-2737

UC Davis Medical Group - Rancho Cordova

3201 Data Dr.
Rancho Cordova, CA 95670
Driving Directions

Primary Phone:
916-851-1440

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

I want to improve the health and quality of life of my patients by a) applying the latest medical knowledge/ best-available medical evidence, b) using an individualized medicine approach and c) caring for my patients with respect and compassion. 

Clinical Interests

Dr. Surampudi's clinical interests include Diabetes & Metabolism, Male Reproductive Medicine (Andrology), Metabolic bone disease/Osteoporosis, and Neuroendocrine Tumors.

Research/Academic Interests

Dr. Surampudi's current research interests center around a) Male Reproductive Endocrinology, b) Diabetes & Metabolism c) Risk factor reduction in Cardiovascular Disease and d) Neuromuscular Endocrinology.

Division

Endocrinology, Diabetes, and Metabolism

Center/Program Affiliation

UC Davis Medical Group

Education

M.D., St. George's University, School of Medicine

B.S., California Institute of Technology, Pasadena CA1997

Residency

Internal Medicine, Mount Sinai School of Medicine- Saint Bamabas Medical Center, Livingston NJ 2004-06

Fellowships

Endocrinology, Diabetes, & Metabolism, Tulane School of Medicine, New Orleans LA 2008-2010

Endocrinology, Diabetes, & Metabolism, UCLA Medical Center-Harbor, Los Angeles CA 2010-2013

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism,

Professional Memberships

American Diabetes Association

American Federation for Medical Research

Andrology Society

Metabolomic Society

The Endocrine Society

Select Recent Publications

Enkhmaa B, Surampudi P, Anuurad E, Berglund L. Lifesyle Changes: Effect of Diet, Exercise, Functional foods and Obesity Treatment on Lipids and Lipoproteins.  Endotext (Chapter 23 ; Section : Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism) http://www.endotext.org/section/lipids/.

Surampudi, PN, Nagireddy, P, Fonseca, V. Colesevelam Hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in type 2 diabetes mellitus. Therapy. Vol. 6, No. 4, Pages 475-487, 2009.

Swerdloff RS, Pak Y, Wang C, Liu PY, Bhasin S, Gill TM, Matsumoto AM, Pahor M, Surampudi P, Snyder PJ. Serum Testosterone (T) Level Variability in T Gel-Treated  Older Hypogonadal Men: Treatment Monitoring Implications. J Clin Endocrinol Metab. 2015 Sep;100(9):3280- 3287.

Surampudi P, Chang I, Lue Y, Doumit T, Jia Y, Atienza V, Liu PY, Swerdloff RS, Wang C. Humanin protects against chemotherapy-induced stage-specific male germ  cell apoptosis in rats. Andrology. 2015 May;3(3):582-9.

Surampudi P, Page ST, Swerdloff RS, Nya-Ngatchou JJ, Liu PY, Christenson P,  Amory JK, Leung A, Hull H, Blithe D, Woo J, Bremner WJ, Christina Wang C. A first  in human study of the pharmacokinetics, safety and food effects of orally  administered DMAU:A prototype oral male hormonal contraceptive  Andrology. 2014 Jul;2(4):579-87.

Surampudi P, Swerdloff RS, Wang C. An update on male hypogonadism therapy. Expert Opin Pharmacother. 2014 Jun;15(9):1247-64

Surampudi PN, Wang C, Swerdloff R Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol. 2012

Thethi TK, Yau CL, Shi L, Leger S, Nagireddy P, Waddadar J, Surampudi P, John- Kalarickal J, Yenoby L, and Fonseca V, Disaster Medicine and Public Health Preparedness.2010; 4: S33-S38.

Surampudi, PN, John-Kalarickal, J, Fonseca, V. Pathophysiology of Type 2 Diabetes Mellitus. Mount Sinai Journal of Medicine. 76:000?000, 2009.